Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 13668-696

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 01)

Structure (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 01)
Chemical structure diagram of lamotrigine showing its molecular framework with two chlorine atoms and several nitrogen and amino groups.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 02)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 02)
A line graph showing failure probability (%) over weeks comparing Lamotrigine and placebo. The x-axis represents time in weeks (0 to 100), and the y-axis indicates failure probability percentage (0 to 100%). Two lines represent the groups: Lamotrigine shows a lower failure probability over time compared to placebo. Censored data points are marked with plus signs.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 03)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 03)
A Kaplan-Meier failure probability plot showing percentage failure probability over time in weeks, comparing Lamotrigine versus placebo. The y-axis represents failure probability (%) and the x-axis represents weeks up to 80. Two curves are shown: one for Lamotrigine with lower failure probability over time, and one for placebo with higher failure probability. Censored data points are marked with crosses.*
FDA Label Image

Logo (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 04)

FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 07)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 07)
Packaging label image showing four strengths of LAMOTRIGINE orally disintegrating tablets by Torrent Pharmaceuticals Limited: 25 mg with imprint "W2", 50 mg with imprint "W3", 100 mg with imprint "W4", and 200 mg with imprint "W5". All tablets are white to off-white, round, flat, radius-edged, uncoated, and debossed with their respective imprint on one side and plain on the other.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 09)

FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 10)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 10)
Label for Lamotrigine Orally Disintegrating Tablets, USP 25 mg, containing 30 tablets. The label includes dosage form and strength, manufacturer information (Torrent Pharmaceuticals Limited), storage instructions, and a caution note to verify product dispensed. It features a barcode, NDC 13668-693-30, and instructions for pharmacists. The label is for prescription use only.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 11)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 11)
Label for Lamotrigine Orally Disintegrating Tablets, USP 50 mg, containing 30 tablets. The label includes storage instructions, dosing note, manufacturer details (Torrent Pharmaceuticals Limited), and cautions for pharmacists to verify product dispensing. Barcode and NDC 13668-694-30 are visible, along with a designated unvarnished area for batch and expiration imprinting.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 12)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 12)
Label for Lamotrigine Orally Disintegrating Tablets, USP 100 mg, containing 30 tablets. The label includes storage instructions, manufacturer details (Torrent Pharmaceuticals Limited), a caution to verify product dispensed, and a barcode. The product is designated for oral use and prescription only.*
FDA Label Image

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 13)

Image Description (E75c1de4 7aaa 4b14 9b73 B2f87d839c7c 13)
Lamotrigine Orally Disintegrating Tablets, USP 200 mg label for 30 tablets by Torrent Pharmaceuticals Limited. The label includes storage instructions, dosage advice pointing to prescribing information, a caution to verify dispensation, and states Rx only. The label shows a batch and expiration area and barcode on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.